FDA Approval Won't Make Stem Cell Therapy Cheaper | #195
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
FDA Approval Won't Make Stem Cell Therapy Cheaper | #195
-
ナレーター：
-
著者：
If you're holding off on stem cell therapy because you're waiting for FDA approval to bring the price down, this is the reality check you need.
Dr. Joy Kong, a triple board certified physician and stem cell specialist at Chara Health, breaks down what FDA approved stem cell products actually cost. Cord blood transplants like Omidacel and AlloCord run $450,000 to $1.2 million. Ryoncil, used for pediatric graft versus host disease, totals $1.55 million. By comparison, current stem cell therapy provided as a legal tissue transplant, the same model used in organ transplants, costs $7,000 to $25,000 per infusion.
Dr. Joy explains why that gap exists, and what it means if you're counting on insurance to make this treatment affordable.
✨ Learn more about how to live a long and pain-free life: https://joykongmd.com/
Dr. Joy talks about:
0:21 Why FDA Approval Doesn't Lower Cost
2:26 Cost Of FDA-Approved Stem Cell Products
3:40 Why Legal Stem Cell Therapy Is Cheaper
Additional Resources
Visit My Clinic: Chara Health
🌐 https://chara-health.com
📍 9568 Topanga Canyon Blvd. Los Angeles, CA 91311
📲 Call (818) 356-8232 or email info@chara-health.com to make an appointment or go to https://www.joykongmd.com and fill out a contact form.
✨ Follow me on Facebook: https://www.facebook.com/stemcelldrjoy/
✨ Follow me on Instagram: https://www.instagram.com/dr_joy_kong/
About Dr. Joy Kong
Dr. Joy Kong is a regenerative medicine and anti-aging expert. Her podcast is part of her mission to reduce suffering and elevate happiness. Join us every week for the latest holistic health insights that will help you live a long and pain-free life.